Type 2 diabetes mellitus (T2DM), formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin.

As a dedicated CRO company, Ace Therapeutics provides a full range of T2DM-related services to leading pharmaceutical, biotechnology, agrochemical, governmentand academic organisations around the world to help you make progress on the discovery of new or modified medications, insulin alternatives or treatments.

Learn more: t2dm therapy development services